| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.
|
Mol Brain
|
2012
|
2.18
|
|
2
|
Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity.
|
Neuron
|
2007
|
2.08
|
|
3
|
Expanding the clinical phenotype of SNCA duplication carriers.
|
Mov Disord
|
2009
|
1.25
|
|
4
|
Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
|
Parkinsonism Relat Disord
|
2012
|
1.05
|
|
5
|
Pilot study of H₂ therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial.
|
Mov Disord
|
2013
|
1.04
|
|
6
|
Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders.
|
Acta Neuropathol
|
2004
|
0.95
|
|
7
|
Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease.
|
Neuroreport
|
2006
|
0.93
|
|
8
|
Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risks.
|
Parkinsonism Relat Disord
|
2013
|
0.92
|
|
9
|
Lewy bodies in progressive supranuclear palsy.
|
Acta Neuropathol
|
2002
|
0.85
|
|
10
|
The effect of Ndrg2 expression on astroglial activation.
|
Neurochem Int
|
2011
|
0.82
|
|
11
|
A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology.
|
Ann Neurol
|
2003
|
0.79
|
|
12
|
Can parkin be a target for future treatment of Parkinson's disease?
|
Expert Opin Ther Targets
|
2013
|
0.77
|
|
13
|
[A 59-year-old woman with personality change and abnormal behavior followed by amyotrophy and dementia].
|
No To Shinkei
|
2005
|
0.77
|
|
14
|
Relationship between Parkinson disease with dementia and dementia with Lewy bodies.
|
Parkinsonism Relat Disord
|
2005
|
0.76
|
|
15
|
Posterior subthalamic area deep brain stimulation for fragile X-associated tremor/ataxia syndrome.
|
Neuromodulation
|
2014
|
0.75
|
|
16
|
[A 67-year-old man with rt. hand resting tremor and rigidity after lt. putaminal hemorrhage].
|
No To Shinkei
|
2005
|
0.75
|
|
17
|
[An 80-year-old woman with progressive stroke, who had rheumatoid arthritis and antiphospholipid syndrome].
|
No To Shinkei
|
2006
|
0.75
|
|
18
|
Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): a comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with progressive supranuclear palsy.
|
Mov Disord
|
2010
|
0.75
|
|
19
|
Effect of adrenergic stimulation on drug absorption via passive diffusion in Caco-2 cells.
|
Int J Pharm
|
2008
|
0.75
|
|
20
|
[A 54-year-old man with familial parkinsonism, gaze palsy, and dementia].
|
No To Shinkei
|
2005
|
0.75
|
|
21
|
Glial localization of four-repeat tau in atypical progressive supranuclear palsy.
|
Neuropathology
|
2004
|
0.75
|
|
22
|
[A 73-year-old woman with depression, dementia, and parkinsonism].
|
No To Shinkei
|
2005
|
0.75
|
|
23
|
[An 81-year-old man with personality change, dementia, and gait disturbance with diffuse leukoaraiosis of the cerebral white matter].
|
No To Shinkei
|
2006
|
0.75
|
|
24
|
[A 52-year-old woman with dyskinesia, epilepsy and gait disturbance].
|
No To Shinkei
|
2002
|
0.75
|
|
25
|
[A 84-year-old man with apraxia and parkinsonism on his left side,who became bedridden for 6 years].
|
Brain Nerve
|
2011
|
0.75
|
|
26
|
[A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
|
No To Shinkei
|
2005
|
0.75
|
|
27
|
Pathological and biochemical studies on a case of Pick disease with severe white matter atrophy.
|
Neuropathology
|
2006
|
0.75
|